Investigation of salivary C-reactive protein and interleukin-18 for the diagnosis of neonatal sepsis
Behzad Barekatain1, Najmeh HasanGhalyaei2, Majid Mohammadizadeh1, Negah Tavakolifard3
1 Department of Pediatrics, Division of Neonatology, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Neonatologist, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Community and family medicine, Isfahan University of Medical Sciences, Isfahan, Iran
|Date of Submission||02-Dec-2020|
|Date of Decision||14-Mar-2021|
|Date of Acceptance||18-Jul-2021|
|Date of Web Publication||22-Dec-2021|
Department of Pediatrics, Division of Neonatology, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan
Source of Support: None, Conflict of Interest: None
Background: Neonatal sepsis is a leading cause of death in neonates worldwide. The investigation of biomarkers for the early diagnosis of neonatal sepsis is in progress with controversial outcomes. The current report aims to evaluate the values of salivary C-reactive protein (CRP) and interleukin-18 (IL-18) for the diagnosis of neonatal sepsis. Materials and Methods: In this cross-sectional study, 89 neonates, including 49 neonatal septic case and 40 healthy group admitted at the neonatal intensive care unit, were evaluated. The salivary samples of IL-18 and CRP were measured before the antibiotic therapy initiation, as soon as blood samplings. Sepsis diagnosis was confirmed by the positive blood culture. The diagnostic values of the biomarkers were determined using the receiver operating characteristic curve (ROC curve) analysis. Besides, the sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) positive likelihood ratio (LR+), negative likelihood ratio (LR-), and diagnostic accuracy were measured. Results: Salivary CRP level was remarkably higher in septic case than healthy group (5.2 ± 4.61 vs. 3.5 ± 1.7; P = 0.02), while salivary IL-18 was not different between the groups (0.1 ± 0.29 vs. 0.04 ± 0.19; P = 0.25). The ROC curve for IL-18 showed insignificant values (P = 0.37). The ROC curve of salivary CRP showed area under the curve of 0.63 (95% confidence interval: 0.51–0.74; P = 0.03) with the sensitivity, specificity, PPV, NPV, LR+, LR − and diagnostic accuracy of 44.9% (31.8–58.7), 80% (65.2–89.5), 73.3% (55.5–85.82), 54.2% (41.6–66.3), 60.6% (50.29–70.18), 2.24 (1.57–3.2), and 0.68 (0.63–0.75) at the cutoff of 4.55 ng/L, respectively. Conclusion: Based on the findings of the current study, salivary CRP can be considered a biomarker for the early diagnosis of neonatal sepsis, while no statistical values for salivary IL-18 were detected. Due to the significance of neonatal sepsis, further evaluations are strongly recommended.
Keywords: C-reactive protein, interleukin-18, neonatal sepsis, saliva
|How to cite this article:|
Barekatain B, HasanGhalyaei N, Mohammadizadeh M, Tavakolifard N. Investigation of salivary C-reactive protein and interleukin-18 for the diagnosis of neonatal sepsis. J Res Med Sci 2021;26:131
|How to cite this URL:|
Barekatain B, HasanGhalyaei N, Mohammadizadeh M, Tavakolifard N. Investigation of salivary C-reactive protein and interleukin-18 for the diagnosis of neonatal sepsis. J Res Med Sci [serial online] 2021 [cited 2022 May 19];26:131. Available from: https://www.jmsjournal.net/text.asp?2021/26/1/131/333282
| Introduction|| |
Neonatal sepsis is a systematic inflammatory response to the bacterial infection within the 1st month of life. Neonatal sepsis is one of the concerning etiologies of morbidity and mortality worldwide estimated to affect 3–5 septic case per 1000 live births worldwide.
Due to the immunological deficiencies in the 1st day of life, neonates cannot respond early and adequately to the infection. Besides, the probable concomitant conditions make it difficult to quickly diagnose neonatal sepsis, and therefore, initiate its management. This challenging condition is better clarified, considering the variations in the clinical manifestations of newborn infections., Accordingly, the early concise diagnosis of neonatal sepsis is a significant concern, and a need for a reliable marker to diagnose neonatal sepsis in early courses is making notifying sense.
Although blood culture is known as the most reliable means for the definite diagnosis of infection, it is considerably time-consuming to grow microorganisms, has the potential of being contaminated, and has false-negative outcomes. In this regard, various cytokines and molecular biomarkers have been introduced; however, they seem far to be widely used in the near future, considering their cost-beneficence.,
C-reactive protein (CRP) is a well-known biomarker used extensively for the diagnosis and follow-up of neonatal sepsis. On the other hand, limitations such as low specificity and comprising the least duration of 3 days to increase makes the diagnosis of sepsis in early stages difficult. Salivary CRP is a more novel marker investigated for the diagnosis of sepsis, and despite the studies that are in early stages, it is directly associated with the serum levels of CRP, as a well-established marker for systematic inflammation. Therefore, studies regarding the detection of reliable markers for the diagnosis of neonatal sepsis are in progress.
Interleukine-18 (IL-18), a member of the IL-1 cytokine super-family, has a substantial role in the pathophysiology of sepsis and regulation of immune response. This cytokine has a crucial role in the induction of both types of T-cells in the context of the immune response. There are studies in the literature representing the association of urinary IL-18 with systematic inflammatory conditions such as sepsis in adults, children, and neonates.,
CRP and IL-18 is the acute-phase reactant and theoretically rise in body liquids as saliva and can predict the inflammatory response of body against sepsis process. Obtaining inflammatory reactants such as CRP and IL-18 through noninvasive methods is preferred to invasive methods such as blood sampling especially in new-borns with lower gestational age because manipulation of new-borns can lead to severe complication such intraventricular hemorrhage and pneumothorax.
In the current study, we are aimed to investigate the values of salivary CRP and salivary IL-18 for the detection of neonatal sepsis.
| Methods|| |
The current cross-sectional study has been conducted on 89 neonates with a gestational age of over 32 weeks admitted at the neonatal intensive care unit (NICU) of hospitals affiliated at Isfahan University of Medical Sciences from April 2017 to November 2018.
All of the neonates with a gestational age of 32 weeks and above admitted at the NICU and their legal guardians represented their willingness for participation in the study were included. Any cardiac or brain anomalies, asphyxia, metabolic or chromosomal disorders, and history of intrauterine gestational retardation were considered as unmet criteria. The impossibility for the follow-up of the patients or over 20% of defect in the medical records was the exclusion criteria of the current study.
The Ethics Committee of Isfahan University of Medical Sciences approved the study protocol. With approval ID: IR.MUI.MED.REC.1397.289. Then, the study protocol was entirely explained for the legal guardians of the patients, and written consent for participation in the study was obtained.
The diseased group was included nonrandomly through convenience sampling until achieving the desired number of the study population. Then, the healthy group who were admitted at NICU due to any reason were entered in the study using a convenience sampling method. The control group was similar to the septic case in terms of inclusion and exclusion criteria except for the diagnosis of sepsis.
The diagnosis of sepsis, whether early-onset sepsis or late-onset sepsis, for the case group, was made based on positive blood cultures sent to the laboratory before the initiation of antibiotic therapy. The blood cultures were reported using a cell counter device, sysmex, Germany. Besides, serum levels of CRP were measured for the diseased group, as well.
The salivary samples of IL-18 and CRP were measured before the antibiotic therapy initiation as soon as possible to the time of blood samplings. In order to maximize the similarity in the sampling, the salivary samples were taken within an hour before the neonates' feeding. Thus a skilled target neonatologist performed the sampling processes by lateral rotating the neonate's head and taking the sample from the sublingual area. One milliliter of salivary secretion was taken sterilely, and for the prevention of contamination, gathered in the polypropylene sample tube. The measurement of IL-18 and CRP was performed immediately following transmission to the laboratory, if possible, or the sample was preserved in −20°C, and the measurements were performed within the next day.
In order to minimize bias, all of the assessments were done in the laboratory of Alzahra Hospital Affiliated at Isfahan University of Medical Sciences using kits made by Hangzhou Eastbiopharm, The United States.
The measurements of salivary CRP and salivary IL-18 were performed for the control group as well.
Data were analyzed using the SPSS software version 20 (IBM Company, Chicago, USA). Mean (standard deviation) and frequency were used to show the continuous and categorical variables. Independent sample t-test and Chi-square tests were used to compare quantitative and qualitative variables between septic and neonate groups. To determine the diagnostic value of serum and salivary CRP and IL-18, indices of sensitivity, specificity, positive and negative diagnostic value (positive predictive value [PPV] and negative predictive value [NPV]), positive likelihood ratio and negative likelihood ratio (LR + and LR−) were used. Furthermore, the receiver operating characteristic curve (ROC curve) and the area under the curve (AUC) with 95% confidence interval (CI) were used to show the accuracy of serum and salivary tests. The level of statistical significance was considered 5%.
| Results|| |
In the current study, 89 participants, including 49 septic case and 40 healthy group, were assessed.
The mean gestational age of the septic case was 34.64 ± 1.43 and healthy group was 38 ± 1.66 (P < 0.0001). There was no statistically significant difference between septic case and healthy group in terms of gender distribution (P = 0.699). [Table 1] represents the demographic information of the studied population in detail.
|Table 1: Comparison of the demographic characteristics of the healthy and septic neonates|
Click here to view
The comparison of salivary CRP and IL-18 between septic case and healthy group revealed significantly higher levels of salivary CRP in septic neonates (P = 0.02), but for IL-18 (P = 0.25) [Table 2].
|Table 2: Comparison of C-reactive protein and interleukin -18 between the neonates with sepsis and healthy group|
Click here to view
Besides, the comparison of salivary versus blood levels of CRP with paired t-test showed higher serum levels than salivary ones in both septic and healthy neonates (4.8 ± 2.66 vs. 4.18 ± 2.76 respectively, P = 0.05).
In the neonatal group with sepsis, salivary and serum CRP levels increase with increasing salivary IL-18 levels, but this relationship was not statistically significant for serum CRP levels (respectively, Spearman's rho = 0.335, P = 0.01 and 0.115, P = 0.45) and there was a statistically significant relationship between serum and salivary CRP levels.(Spearman's rho = 0.657, P < 0.0001).
In the following, the ROC curves representing the values of salivary CRP and IL-18 are demonstrated. Based on [Figure 1] and [Figure 2], the AUC for salivary and serum CRP and salivary IL-18 markers for the diagnosis of neonatal sepsis is given in [Table 3]. The AUC was statistically significant AUC = 0.630 ± 0.05 (95% CI: 0.51–0.74), and P = 0.03 for the salivary, but for IL-18 with AUC = 0.557 (95% CI: 0.43–0.67) and P = 0.37 [Table 3].
|Table 3: The area under the curve for salivary and serum C-reactive protein and salivary interleukine-18 for the neonatal sepsis diagnosis|
Click here to view
|Figure 1: Receiver operating characteristic curve of salivary C-reactive protein for the detection of neonatal sepsis; area under the curve = 0.630, 95% confidence interval: 0.51–0.74, P = 0.035|
Click here to view
|Figure 2: Receiver operating characteristic curve of salivary interleukin -18 for the detection of neonatal sepsis; area under the curve = 0.557, 95% confidence interval: 0.43–0.67, P = 0.36|
Click here to view
The diagnostic value of salivary CRP level in determining sepsis in neonates was statistically significant and the best cutoff for it was at the level of 4.55 ng/L so that sensitivity, specificity, PPV, NPV, LR+, LR − and diagnostic accuracy of the test at different levels of this marker are given in [Table 4].
|Table 4: Assessment of the diagnostic value of different levels of salivary C-reactive protein for the neonatal sepsis diagnosis|
Click here to view
| Discussion|| |
Despite the overall progression in the antimicrobial therapy and life support provisions in the NICUs, neonatal sepsis is still a major etiology of morbidity and mortality worldwide. The early and definite diagnosis of sepsis plays a substantial role in the prevention of the abundant useless antibiotics administration and also the prevention of morbidities and mortality incidence. On the other hand, sepsis signs and symptoms mimic other neonatal-related complications such as apnea of prematurity, transient tachypnea, meconium aspiration syndrome, respiratory distress syndrome, and acute exacerbation of chronic lung disease that are indistinguishable from early presentations of sepsis. Besides, hesitate to initiate antimicrobial therapy in order to diagnose sepsis definitely may cause deterioration of sepsis, leading to irrecoverable complications such as intravascular coagulation. Accordingly, achieving a reliable biomarker for the early diagnosis of sepsis is crucial; however, yet we have not achieved a precise biomarker for early and definite diagnosis of neonatal sepsis.
To the best of our knowledge, the current presentation is the first one assessing the values of salivary interleukin -18 and among the limited ones assessing salivary CRP for the diagnosis of neonatal sepsis. In this regard, we found significantly higher levels of salivary CRP among the septic neonates as compared to the healthy ones, while the outcomes for IL-18 were not statistically different. Further evaluations showed a significant direct association between the salivary levels of CRP with serum levels of this biomarker, as the most popular marker for the diagnosis of systematic inflammation in the body.
The other investigation of our study revealed insignificant predictive values for IL-18 (P > 0.05), while salivary CRP had the significant value for the prediction of sepsis (P = 0.035; 95% CI: 0.51–0.74), with sensitivity and specificity of 49% and 80% at the cutoff level of 4.55 ng/L, respectively.
CRP is a positive reactant protein produced by hepatic tissue in response to trauma, cellular damage, tissue injury, and infection. The first traces of CRP increase would appear within 6 h, while its peak levels are detectable within 48–72 h and remain high until infection resolved., The statistically higher serum levels of CRP among the septic neonates in comparison to healthy ones have been reported previously; however, there are studies in which normal levels of this biomarker have been represented, while the blood culture was positive in neonates, low birth weight (LBW) ones in particular. In general, studies in terms of serum CRP have demonstrated the wide ranges of sensitivity and specificity, ranging from 35% to 94% and 60%–96%, respectively. The ranges are consistent with our findings; however, they are achieved through blood sampling, an invasive procedure for LBW neonates, while our outcomes are derived from salivary samples.
Similar to our study, the direct association of salivary CRP with serum levels of CRP, as the major inflammatory marker, has been represented in the literature. Iyengar et al. reported a slight but significant direct correlation between the measured salivary CRP and the serum levels of CRP among neonates with sepsis, whether new-onset, or late-onset, or in general. This correlation has been shown by Gutiérrez et al., Dillon et al., and Ouellet-Morin et al., as well. This direct correlation of salivary CRP levels with its serum levels on a hand and its rapid elevation in the sepsis only within 6 h better clarifies the value of salivary CRP for the early detection of sepsis.
Similar to our report, there are other studies in the literature representing the notifying values for the salivary CRP to detect neonatal sepsis. Iyengar et al. conducted a study in order to assess the values of salivary CRP for the diagnosis of sepsis. Therefore, salivary samples were taken from 40 neonates with positive blood cultures. The samples were primarily taken prior to the antibiotic initiation, and they found remarkable sensitivity and specificity of 64% and 94% at cut-off levels of 10 mg/L of salivary CRP levels. In addition, they found a statistically significant association of neonatal sepsis with salivary CRP levels at the cut-off of 5 mg/L with sensitivity and specificity of 54% and 95%, as well. In this term, a similar study was conducted by Omran et al. in Egypt in 2018. They assessed 70 full-term neonates, among which 35 ones were healthy, 20 ones had positive blood cultures, and sepsis diagnosis was made clinically for 15 remained ones. In this study, they declared significant specificity and sensitivity of 93.4% and 80% at the cutoff of 3.48 ng/L, respectively.
A few studies have assessed the use of interleukin-18 for the diagnosis of critical illnesses. Besides, most of the researchers have assessed the values of urinary or serum, but salivary ones. These studies have shown the sharper rise in the interleukine-18 levels than CRP, which shows the merit of IL-18 for early detection of sepsis. Wagner et al. and Kingsmore et al. have separately used serum levels of IL-18 as the marker for the early diagnosis of neonatal sepsis, and unanimously declared the value of this biomarker for the detection of sepsis. Moreover, Cui et al. not only represented elevated serum levels of IL-18 among critically ill adults, but they also found elevated plasma miRNA expression of IL-18, as well.
Li et al. conducted a study on 111 neonates divided into two groups of septic case versus healthy group. Contrary to our findings, they represented considerably increased levels of elevated urinary interleukine-18 among the septic neonates as compared to healthy group, while the limitation of their study was the small number of septic case as compared with the healthy group.
Higazi et al. conducted their study to evaluate the best cut-off for the urinary IL-18 for the early detection of neonatal sepsis. In their study, the cut-off of 8.85 μg/ml of urinary IL-18 had the remarkable sensitivity of 91.2% and specificity of 100%.
In summary, in our investigation, the salivary CRP was significantly higher among septic neonates than healthy ones, the salivary CRP was directly correlated with its serum levels, and eventually, salivary CRP levels at the cutoff of 4.55 ng/L had the prognostic values for early diagnosis of sepsis. Our findings were consistent with a few numbers of studies in this regard that represented statistical cutoffs for salivary CRP at diverse levels. On the other hand, salivary interleukin -18 was not considerably different among septic case versus healthy ones. Contrasting results were presented by other studies using urinary and serum interleukin -18.
CRP is the acute phase reactant and theoretically rise in body liquids as saliva and can predict the inflammatory response of body against sepsis process.
One of the limitations of this study was related to the sample size, which was too small to be generalizable to the entire community, and further studies should be conducted with larger sample sizes.
Another limitation was the lack of measuring serial of salivary CRP. As the current study was the first one investigating salivary IL-18, further studies are recommended.
| Conclusion|| |
Based on the findings of the current study, salivary CRP at the level of 4.55 ng/L has the statistical values for the diagnosis of sepsis in LBW neonates with the sensitivity of 49% and specificity of 80%, while no statistical values of salivary IL-18 for the early diagnosis of sepsis was detected.
This study represents elementary evidence about usefulness of salivary CPR combined with serum CRP in the diagnosis of neonatal sepsis, although these data need to be verificated by another studies with larger numbers of newborn.
This study performed on premature neonates in the hospitals affiliated at Isfahan University of Medical Sciences from April 2017 to November 2018 (research project number 397422). We would like to thank the nurses and officials of Alzahra Hospital. The Ethics Committee of Isfahan University of Medical Sciences approved the study protocol (IR.MUI.MED.REC.1397.289).
Financial support and sponsorship
This study was funded by vice-chancellor for Research and Technology of Isfahan University of Medical Sciences.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Shah BA, Padbury JF. Neonatal sepsis: An old problem with new insights. Virulence 2014;5:170-8.
Tosson AM, Speer CP. Microbial pathogens causative of neonatal sepsis in Arabic countries. J Matern Fetal Neonatal Med 2011;24:990-4.
Manoura A, Gourgiotis D, Galanakis E, Matalliotakis E, Hatzidaki E, Korakaki E, et al.
Circulating concentrations of α-and β-chemokines in neonatal sepsis. Int J Infect Dis 2010;14:e806-9.
Cetinkaya M, Ozkan H, Köksal N, Celebi S, Hacimustafaoğlu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol 2009;29:225-31.
Mussap M, Noto A, Cibecchini F, Fanos V. The importance of biomarkers in neonatology. Semin Fetal Neonatal Med 2013;18:56-64.
Çelik HT, Portakal O, Yiğit Ş, Hasçelik G, Korkmaz A, Yurdakök M. Efficacy of new leukocyte parameters versus serum C-reactive protein, procalcitonin, and interleukin-6 in the diagnosis of neonatal sepsis. Pediatr Int 2016;58:119-25.
Delanghe JR, Speeckaert MM. Translational research and biomarkers in neonatal sepsis. Clin Chim Acta 2015;451:46-64.
Iyengar A, Paulus JK, Gerlanc DJ, Maron JL. Detection and potential utility of C-reactive protein in saliva of neonates. Front Pediatr 2014;2:131.
Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001;19:423-74.
Nejat M, Pickering JW, Walker RJ, Westhuyzen J, Shaw GM, Frampton CM, et al.
Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 2010;14:R85.
Li Y, Li X, Zhou X, Yan J, Zhu X, Pan J, et al.
Impact of sepsis on the urinary level of interleukin-18 and cystatin C in critically ill neonates. Pediatr Nephrol 2013;28:135-44.
Ng PC. Clinical trials for evaluating diagnostic markers of infection in neonates. Biol Neonate 2005;87:111-2.
Higazi A, Mahrous D, Sayed S, Mohamed O, Aly S. Assessment of urinary interleukin-18 and serum amyloid A efficacies against C-reactive protein in diagnosis and follow-up of neonatal sepsis. J Clin Cell Immunol 2016;7:2.
İpek İÖ, Saracoglu M, Bozaykut A. α1-Acid glycoprotein for the early diagnosis of neonatal sepsis. J Matern Fetal Neonatal Med 2010;23:617-21.
Arnon S, Litmanovitz I, Regev R, Lis M, Shainkin-Kestenbaum R, Dolfin T. The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants. J Perinat Med 2004;32:176-80.
Hisamuddin E, Hisam A, Wahid S, Raza G. Validity of C-reactive protein (CRP) for diagnosis of neonatal sepsis. Pak J Med Sci 2015;31:527-31.
Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: Current insights and new tasks. Neonatology 2012;102:25-36.
Shortland DB, MacFadyen U, Elston A, Harrison G. Evaluation of C. reactive protein values in neonatal sepsis. J Perinat Med 1990;18:157-63.
Aydemir C, Aydemir H, Kokturk F, Kulah C, Mungan AG. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis. BMC Pediatr 2018;18:253.
Gutiérrez AM, Martínez-Subiela S, Eckersall PD, Cerón JJ. C-reactive protein quantification in porcine saliva: A minimally invasive test for pig health monitoring. Vet J 2009;181:261-5.
Dillon MC, Opris DC, Kopanczyk R, Lickliter J, Cornwell HN, Bridges EG, et al.
Detection of homocysteine and C-reactive protein in the saliva of healthy adults: Comparison with blood levels. Biomark Insights 2010;5:57-61.
Ouellet-Morin I, Danese A, Williams B, Arseneault L. Validation of a high-sensitivity assay for C-reactive protein in human saliva. Brain Behav Immun 2011;25:640-6.
Omran A, Maaroof A, Saleh MH, Abdelwahab A. Salivary C-reactive protein, mean platelet volume, and neutrophil-lymphocyte ratio as diagnostic markers for neonatal sepsis. Jornal de Pediatria 2018;94:82-7.
Wagner TA, Gravett CA, Healy S, Soma V, Patterson JC, Gravett MG, et al.
Emerging biomarkers for the diagnosis of severe neonatal infections applicable to low resource settings. J Glob Health 2011;1:210-23.
Kingsmore SF, Kennedy N, Halliday HL, van Velkinburgh JC, Zhong S, Gabriel V, et al.
Identification of diagnostic biomarkers for infection in premature neonates. Mol Cell Proteomics 2008;7:1863-75.
Cui YL, Wang B, Gao HM, Xing YH, Li J, Li HJ, et al.
Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia. Patient Prefer Adherence 2016;10:313-9.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4]